Efferon Jsc
Clinical trials sponsored by Efferon Jsc, explained in plain language.
-
New blood filter may shield heart surgery patients from organ failure
Disease control Recruiting nowThis study tests a device called Efferon LPS that filters harmful substances from the blood during and after heart surgery. The goal is to see if it can reduce the risk of multiple organ failure, a serious complication. Researchers will enroll 60 adults having heart surgery with …
Phase: NA • Sponsor: Efferon JSC • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New blood filter could save lives in severe pancreatitis
Disease control Recruiting nowThis study tests a device called Efferon LPS that filters toxins and inflammatory substances from the blood. It is being given to 150 people with severe acute pancreatitis within 24 hours of ICU admission. The goal is to see if it reduces organ failure and improves outcomes compa…
Phase: NA • Sponsor: Efferon JSC • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New blood filter could speed recovery for burn victims
Disease control Recruiting nowThis pilot study tests a device called Efferon LPS that filters the blood to remove toxins and inflammatory substances in adults with severe thermal burns. Fifteen participants will receive two filtering sessions, and their outcomes will be compared to a group of similar patients…
Sponsor: Efferon JSC • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New device aims to clean blood of burn toxins
Disease control Recruiting nowThis study tests a device called Efferon LPS NEO that filters the blood of children with severe burns to remove harmful substances. The goal is to see if it reduces time in the ICU and improves recovery. Thirty children will receive the treatment and be compared to past cases.
Sponsor: Efferon JSC • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC